Best Dow Dividend Stocks To Own Right Now

The price of copper has been falling, and so have shares of copper miners. The bad news is that the International Copper Study Group expects further discrepancies between supply and demand. It projects that the growth rate of global refined copper usage will be at least 1.2 percentage points below total refined copper production’s growth rate in 2013 and 2014. Some miners are still worth looking at, but you need to dig down and take a long-term view.

Copper LME Settlement Price data by YCharts

The big picture
Construction is one of the biggest drivers of copper demand, and slowing industrialization in the emerging markets is creating a bear market. The copper industry needs to realize that falling growth rates in China will decrease future demand, and fewer mines need to be opened. Downward pressure on copper prices may be a blessing in disguise, as it will help decrease the number of new mines brought online. 

Best Dow Dividend Stocks To Own Right Now: Scripps Networks Interactive Inc(SNI)

Scripps Networks Interactive, Inc. operates as a lifestyle content company in the United States and internationally. It engages in the operation of television networks, including Home and Garden Television, Food Network, Travel Channel, DIY Network, Cooking Channel, and Great American Country. The company also operates Websites, including FoodNetwork.com, Food.com, CookingChannelTV.com, HGTV.com, DIYnetwork.com, and Travelchannel.com that are associated with its television networks and other Internet-based businesses serving food, home, and travel related categories. Scripps Networks Interactive, Inc. is headquartered in Knoxville, Tennessee.

Advisors’ Opinion:

  • [By Will Ashworth]

    Next Page

    Top Potential Buyouts: #2, Scripps Networks Interactive (SNI)/AMC Networks

    In February, I discussed potential buyouts that could take place within the cable industry. One of the scenarios I mentioned was a merger between Scripps Networks Interactive (SNI) and AMC Networks (AMCX). The combined entity would have three of the top cable networks in terms of viewership with AMC, HGTV and Food Network. Both companies are family-controlled, so any deal would require the support of both the Dolans (AMC) and Scripps (HGTV, Food Network).

  • [By Sara Hov]

    Scripps Networks Interactive (NYSE: SNI  ) looks stronger than ever after a great first quarter. 

    While most cable networks experienced a dip in viewership largely because of the Olympics, Scripps’ popular channels — including HGTV, Food Network, and Travel Channel — actually increased viewership numbers, especially in the key 25- to 54-year-old demographic advertisers covet.

  • [By Will Ashworth]

    Somebody will buy Scripps Networks Interactive (SNI), given that HGTV and Food Network are both in the top 20. It looked momentarily like Discovery Communications (DISCA) might be the suitor, but the company backed out of talks this past week, preferring to focus on overseas expansion.

Best Dow Dividend Stocks To Own Right Now: Full Circle Capital Corporation (FULL)

Full Circle Capital Corporation is a business development company and operates as an externally managed non-diversified closed-end management investment company. It invests in debt and equity securities of smaller and lower middle-market companies with annual revenues between $3 million and $75 million. The company primarily invests in various categories of debt comprising asset-based senior secured loans, subordinated or unsecured loans, and mezzanine loans. It seeks to invest in a range of industries with a focus on media, communications, and business services. The company primarily seeks to invest between $3 million and $10 million. However, it can also make larger investments.

Advisors’ Opinion:

  • [By Monica Wolfe]

    Full Circle Capital Corp (FULL)

    Over the past week there were two insiders making four buys into Full Circle Capital.  These buys come as the company’s price has hit its lowest price since Nov. 2011.

Best Dow Dividend Stocks To Own Right Now: ResMed Inc (RMD)

ResMed Inc., (ResMed), incorporated on March 31, 1994, is a holding company for the ResMed Group. The Company, through its subsidiaries, is a developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. Sleep-disordered breathing (SDB) includes obstructive sleep apnea (OSA), and other respiratory disorders that occur during sleep. The Company has developed a number of products for SDB and other respiratory disorders including airflow generators, diagnostic products, mask systems, headgear and other accessories. Its manufacturing operations are located in Australia, Singapore, France, Germany, Malaysia and the United States. Its distribution and sales sites are located in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Japan, Norway and Sweden. In December 2013, ResMed Inc acquired Unimedis SRO, a surgical appliance and manufacturing company.

Air Flow Generators

The Company produces continuous positive airway pressure (CPAP), variable positive airway pressure (VPAP) and AutoSet systems for the titration and treatment of SDB. The flow generator systems deliver positive airway pressure through a patient interface, either a small nasal mask, nasal pillows system, or full-face mask. Its VPAP units deliver bilevel therapy. There are two preset pressures: a higher pressure as the patient breathes in, and a lower pressure as the patient breathes out. AutoSet systems are based on a technology to monitor breathing and can also be used in the diagnosis, treatment and management of OSA. The Company’s Stellar 100 and 150 ventilation devices, provide both invasive and non invasive ventilation applications for adult and pediatric patients.

ResMed Inc.’s CPAP products include S8 Escape, S9 Elite and S9 Escape. Its VPAP products include VPAP III STA with QuickNav, VPAP S / VPAP IV, VPAP IV ST, S8 Auto 25, VPAP Tx Lab System, S9 VPAP S, S9 VPAP ST! , S9 VPAP Auto, S9 VPAP Adapt, S9 AutoSet CS, S9 Auto 25 and S9 VPAP COPD. The Company’s automatic positive airway pressure products include S9 AutoSet and S9 Escape Auto. Its ventilation products include Elisee 150, VS III and Stellar 100 and 150.

Masks, Accessories, Motors and Diagnostic Products

Masks, accessories, motors and diagnostic products together accounted for approximately 46% of its net revenues in fiscal 2012. Its Mask products include Activa LT, Swift LT for Her, Swift FX, Mirage SoftGel, Quattro FX, Swift FX for Her, Mirage FX, Mirage FX for Her, Pixi Pediatric Mask, Quattro FX for Her, Swift FX Bella, Quattro Air and Swift FX Nano. Its diagnostic products includes ApneaLink + Oximetry and ApneaLink Plus (U.S.)

Accessories and Other Products

The Company to assist those professionals diagnosing or managing the treatment of patients have data communications and control products, such as the EasyCare, ResLin k, ResControl, ResControl II, TxControl, ResScan and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. These products include humidifiers, such as H5i and H4i, which connect directly with the CPAP, VPAP and AutoSet flow generators to humidify and heat the air delivered to the patient, helping to prevent the drying of nasal passages that can cause discomfort. Other optional accessories include cold passover humidifiers, carry bags and breathing circuits. The Company’s data/patient management products include S9 Embletta Adapter, ResScan v3.14, ResTraxx v17.1., ResTraxx v18.3, ResScan v3.16 and EasyCare 1.0.

The Company competes with Philips BV, DeVilbiss Healthcare., Fisher & Paykel Healthcare Corporation Limited, Apex Medical Corp, BMC Medical Co. Ltd and Weinmann Gerate fur Medizin GmbH + Co. KG.

Advisors’ Opinion:

  • [By Roberto Pedone]

     

    Another earnings short-squeeze prospect is medical equipment player ResMed (RMD), which is set to release numbers on Wednesday after the market close. Wall Street analysts, on average, expect ResMed to report revenue of $400.01 million on earnings of 64 cents per share.

     

    The current short interest as a percentage of the float for ResMed is extremely high at 25.6%. That means that out of the 139.26 million shares in the tradable float, 35.89 million shares are sold short by the bears. The bears have also been increasing their bets from the last reporting period by 5%, or by about 1.72 million shares. If the bears get caught pressing their bets into a bullish quarter, then shares of RMD could easily trend sharply higher post-earnings as the shorts rush to cover some of their positions.

     

    From a technical perspective, RMD is currently trending above its 50-day moving average and just below its 200-day moving average, which is neutral trendwise. Shares of RMD have started to flirt with a near-term breakout trade today, since the stock has tested some past overhead resistance at $48.07 a share. That move is starting to push shares of RMD within range of triggering a much bigger breakout trade post-earnings.

     

    If you’re bullish on RMD, then I would wait until after its report and look for long-biased trades if this stock manages to break out above some key overhead resistance levels at $51.22 to $51.32 share with high volume. Look for volume on that move that hits near or above its three-month average action of 1.17 million shares. If that breakout hits post-earnings, then RMD will set up to re-fill some of its previous gap-down-day zone from October of 2013 that started just above $56 a share. If that gap gets filled with strong upside volume flows, then RMD could easily trend north of $60 a share.

     

    I would simply avoid RMD or look for short-biased trades if after earnings

  • [By Damian Illia]

    A Delaware corporation formed in 1994, ResMed Inc. (RMD) is a global leading designer, developer, manufacturer and marketer of medical products for the diagnosis, treatment and management of sleep-disordered breathing (SDB) and other respiratory disorders. For the quarter ended in Dec. 31, 2013 ResMed reported a 2 percent increase (a 1 percent increase in constant currency basis) in revenue over the quarter ended in Dec. 31, 2012. However, these earnings failed to meet analyst estimates; and not without a reason. A relatively poor performance was expected due to continued pressure in the United States, especially as a consequence of the market’s restructuring due to competitive Medicare bidding. This might also be one of the reasons why this stock still remains undervalued.

  • [By Ben Levisohn]

    Resmed (RMD) has plunged 12% to $49.50 in after-hours trading after it reported a profit of 56 cents, below estimates of 58 cents.

    Cliffs Natural Resources (CLF) has gained after it reported a profit of 68 cents, missing forecasts for 71 cents, but beat on revenue.

  • [By Seth Jayson]

    Basic guidelines
    In this series, I examine inventory using a simple rule of thumb: Inventory increases ought to roughly parallel revenue increases. If inventory bloats more quickly than sales grow, this might be a sign that expected sales haven’t materialized. Is the current inventory situation at ResMed (NYSE: RMD  ) out of line? To figure that out, start by comparing the company’s inventory growth to sales growth. How is ResMed doing by this quick checkup? At first glance, pretty well. Trailing-12-month revenue increased 10.0%, and inventory decreased 9.3%. Comparing the latest quarter to the prior-year quarter, the story looks decent. Revenue increased 9.9%, and inventory shrank 9.3%. Over the sequential quarterly period, the trend looks healthy. Revenue grew 1.9%, and inventory dropped 14.5%.

Best Dow Dividend Stocks To Own Right Now: Whitecap Resources Inc (SPGYF.PK)

Whitecap Resources Inc., formerly Spitfire Energy Ltd., is engaged in the exploration, development and production of crude oil, natural gas and natural gas liquids in Western Canada. The Company’s activities are concentrated primarily in Northwest Central Alberta and Southwest Saskatchewan. On July 1, 2010, the Company amalgamated with its wholly owned subsidiary Whitecap Resources Inc. During fiscal 2010, the Company produced an average of 355 barrels of oil equivalent per day (boed). On July 12, 2010, the Company entered into an agreement to acquire a private company. The primary assets to be acquired are located in the Pembina region of west central Alberta with production and reserves focused in the Cardium formation. In October 2013, the Company announced that it has completed the acquisition of a Cardium light oil property and a working interest consolidation of its Eagle Lake Viking unit. Advisors’ Opinion:

  • [By Caiman Valores]

    The recent surge in oil prices has renewed investor interest in the small-cap oil and gas E&P sector. One company that stands out for all the right reasons is Canadian domiciled small-cap, Whitecap Resources (SPGYF.PK). Since 2009 the company has unlocked considerable value for investors through a range of acquisitions as well as development and exploration projects. This has seen its share price surge in value to be up by almost 53% over the last year alone. However, it is clear that the market has yet to fully recognize the true value of Whitecap and there is still considerable upside potential of over 30% for investors. This along with Whitecap’s dividend growth strategy makes it a particularly appealing deep-value investment in the oil and gas E&P sector.

Best Dow Dividend Stocks To Own Right Now: Micromem Technologies Inc (MMTIF)

Micromem Technologies Inc. (Micromem), incorporated on October 21, 1985, is a development-stage company. The Company is engaged in the development of memory technology that has the characteristics of non-volatility, which is the ability to retain information after power has been shut off. The Company is focused on magnetic sensor applications. The Company is focused on research and development of nano-magnetic random access memory (MRAM). Micromem operates in a single segment as a developer of non-volatile magnetic memory and sensor technology. The Company partners with industry to manufacture.

The Company’s technology is based on the ability to use magnetic materials in combination with a sensor to record the state of magnetization. Each magnetic element stores one bit of data based on its ability to alternate between states of magnetic polarization, which states are determined by a sensor.

The Company competes with IBM.

Advisors’ Opinion:

  • [By Peter Graham]

    At the end of last week, small cap stocks Senesco Technologies, Inc (OTCBB: SNTI), VolitionRX Ltd (OTCMKTS: VNRX) and Micromem Technologies Inc (OTCBB: MMTIF) were all trending upwards – ending up 13.65%, 8.73% and 7.61%, respectively, on Friday. However, it’s a new trading week with the last two trading days for the year. So what direction will these three small caps head in for the end of this year and into next year? Here is a quick look to help you decide on a trading or investment strategy:

Best Dow Dividend Stocks To Own Right Now: PIMCO Income Strategy Fund II(PFN)

PIMCO Income Strategy Fund II is a closed-ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. It is co-managed by Pacific Investment Management Company LLC. The fund invests in the fixed income markets of the United States. It invests in securities of companies operating across the diversified sectors. The fund invests in floating-rate debt instruments primarily high-yield senior floating-rate loans. It employs fundamental analysis with top-down approach to create its portfolio. The fund conducts an in-house research to make its investments. It was formerly known as PIMCO Floating Rate Strategy Fund. PIMCO Income Strategy Fund II was formed on June 30, 2004 and is domiciled in the United States.

Advisors’ Opinion:

  • [By John Gerard Lewis]

    Pimco Income Strategy II Fund (PFN) – 15% Allocation

    Pimco has a mind-boggling number of fixed-income offerings, all, at least by reputation, influenced by the philosophies of legendary "bond king" Bill Gross. PFN is the pick here, though, because it yields about 9.5% while selling at roughly 2% below NAV. And it’s personally managed by Mr. Gross.

Best Dow Dividend Stocks To Own Right Now: Roche Holding AG (RHHBY)

Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. The Company belongs to the Roche Group that operates through numerous subsidiaries and associated companies located around the world. The Company’s products and services cover every stage of the healthcare process, from identifying disease susceptibilities and testing for disease in at-risk populations to prevention, diagnosis, therapy and treatment monitoring. Roche operates through two divisions: Pharmaceuticals and Diagnostics. Within the Pharmaceuticals Division there are three sub-divisions: Roche Pharmaceuticals, Genentech and Chugai. The Company’s Diagnostics Division includes five sub-divisions: Applied Science, Diabetes Care, Molecular Diagnostics, Tissue Diagnosis and Professional Diagnostics. Its activities are structured into six geographical segments: North America; Asia-Pacific; Western Europe; Latin America; Central and Eastern Europe, Middle East and Africa (CEMAI), and Jap an. In March 2009, the Company completed the acquisition of Genentech, Inc. In March 2010, the Company acquired assets from BioMicro Systems for all products associated with the Roche NimbleGen microarray workflow.

During the year ended December 31, 2008, the Company Pharmaceuticals Division marketing gained approvals for its rheumatoid arthritis medicine Actemra/RoActemra in Japan, Switzerland and the European Union. In 2008, the division initiated 12 new phase III projects in, including clinical trials of the compounds pertuzumab, for breast cancer; taspoglutide, for type two diabetes, and dalcetrapib, for cardiovascular risk reduction. As of December 31, 2008, the Pharmaceuticals Division filed 11 major new marketing applications and gained 13 major regulatory approvals. At the beginning of 2009, the division’s research and development pipeline comprised 120 clinical projects, including 62 new molecular entities (NMEs) and 58 additional indications. Forty N MEs are in phase I, 16 in phase II and six in phase III or f! iled for regulatory review.

In 2008, Roche Pharmaceuticals signed a total of 57 new agreements including seven product transactions and 43 research and technology collaborations. In May 2008, Roche acquired Piramed Limited, a UK company with therapeutic research programmes targeting the PI3-kinase pathway in oncology and inflammatory disease. In June 2008, signed licensing agreement with ThromboGenics and BioInvent for their jointly developed anticancer agent TB-403 (R7334). In September, 2008, the Company acquired Mirus Bio Corporation active in the field of ribonucleic acid interference (RNAi) delivery and completed the acquisition of ARIUS Research Inc., which has a antibody platform that identifies and selects antibodies based on their functional ability to affect disease. S Research Inc. In January 2009, Roche acquired Memory Pharmaceuticals, which develops drug candidates for the treatment of debilitating central nervous system disorders such as Alzheimer ’s disease and schizophrenia.

Pharmaceuticals

Within Pharmaceuticals division, the Company is engaged in the provision of drugs the areas of oncology, anemia, cardiovascular diseases, central nervous system, infectious diseases, inflammatory and autoimmune diseases, metabolic disorders, cancer, transplantation and virology. The products offered by Roche’s Pharmaceuticals division include MabThera/Rituxan, Herceptin, Avastin, Tamiflu, CellCept, NeoRecormon, Epogin, Pegasys, Tarceva, Xeloda, Bonviva, Boniva, Lucentis, Tamiflu, Xolair, Valcyte, Cymevene, Xenical, Pulmozyme, Nutropin, Neutrogin, Rocephin, Activase, TNKase and Madopar. The products offered by the Pharmaceuticals division are sold in seven geographic regions: North America; Asia-Pacific; Western Europe; Latin America; Central and Eastern Europe, Middle East and Africa (CEMAI), and Japan.

Diagnostics

Roche’s Diagnostics Division is a supplier of in vitro dia gnostics (IVDs). Its products are used to test body fluids a! nd tissue! samples to obtain information for the purpose of preventing, diagnosing, treating and monitoring disease. The Company has business areas five within the diagnostics division: Professional Diagnostics, Diabetes Care, Tissue Diagnostics, Molecular Diagnostics and Applied Science. Roche’s Diagnostics division provides IVD services, including centralized laboratory testing and point-of-care diagnostics to molecular diagnostics and diabetes self management. In addition, it supplies research tools to life scientists.

Roche Professional Diagnostics supplies instrument systems, tests, software and services. It provides point-of-care testing products to support clinical decision-making close to the patient, in doctors’ offices, emergency rooms and other primary and specialty care settings. Twelve Serum Work Area assays were rolled out during the year ended December 31, 2008, across Europe and in other markets. New assays included the Elecsys anti-TSH receptor antib ody assay for the diagnosis of Graves’ disease the Elecsys anti-CCP antibody assay, a test to aid the diagnosis of rheumatoid arthritis, and the Roche Cystatin C clinical chemistry test for early detection of impaired kidney function, among others. Roche Diabetes Care’s products portfolio covers the entire diabetes self-management spectrum, from glucose monitoring to insulin delivery, as well as monitoring systems with integrated lancets and test strips software for storing and analyzing data. Roche Tissue Diagnostics develops and manufactures medical diagnostic instruments and reagent systems that provide automation technology for use in the diagnosis and prognosis of cancer and infectious disease. In 2008 Roche Tissue Diagnostics launched ofhe Bench- Mark Ultra, a system that performs immunohistochemistry and in situ hybridisation testing simultaneously on a single continuous and random access platform. Roche Molecular Diagnostics develops and commercializes diagnostic and blood screening platforms and tests based on Roche’s ! real-time! polymerase chain reaction (PCR) technology. Applied Science business area supplies a specific reagents and test kits for use in life sciences encompassing biology, biotechnology ,medical research, as well as disease areas like cancer and virology. Applied Science’s business area product portfolio includes such sequencing systems as LightCycler 480, LightCycler 480 II, GS FLX Titanium. In addition, Applied Science offers xCELLigence cell analyzer.

Advisors’ Opinion:

  • [By James E. Brumley]

    Look out Roche Holding Ltd. (OTCMKTS:RHHBY), and Opko Health Inc. (NYSE:OPK) – you’re on notice too. There’s a new player in the human growth hormone arena, and it may have built the proverbial better mousetrap. Versartis Inc. (NASDAQ:VSAR) only went public in late March, but with the dust from that IPO settling, it’s already becoming clear that VSAR – admittedly a one-trick pony – could pose a real threat to OPK and RHHBY… at least on the human growth hormone front.

  • [By James E. Brumley]

    I hate to be the one to say I told you so, but, I told you so. Back on February 26th I suggested IsoRay, Inc. (NYSEMKT:ISR) shares were a budding breakout play. The 48% rally that’s played out for ISR in the meantime unfurled right on cue. While overbought in the very short run, this small cap stock looks like it’s earning the right to be compared to the likes of bigger brothers in the cancer-treatment space… names like Roche Holding Ltd. (OTCMKTS:RHHBY) or Theragenics Corporation (NYSE:TGX).

  • [By Bryan Murphy]

    No, it’s no Amgen, Inc. (NASDAQ:AMGN) yet, and it’s not ready to go toe-to-toe with Roche Holding Ltd. (OTCMKTS:RHHBY) either. But, when you read between the lines with TNI Biotech Inc. (OTCMKTS:TNIB) – or take a big step back and look at the bigger picture for TNIB – you have to wonder if it’s now a better investment opportunity than RHHBY or AMGN are.

  • [By Michael Robinson]

    In December, Prothena signed a deal with drug giant Roche Holding AG (RHHBY) to develop and commercialize Parkinson’s treatments that could be worth up to $600 million.

Best Dow Dividend Stocks To Own Right Now: Rock-Tenn Co (RKT)

Rock-Tenn Company (RockTenn), incorporated on September 20, 1985, is a North America’s integrated manufacturer of corrugated and consumer packaging. The Company operates locations in the United States, Canada, Mexico, Chile, Argentina, Puerto Rico and China. The Company operates in three segments: Corrugated Packaging, consisting of its containerboard mills and its corrugated converting operations; Consumer Packaging, consisting of its coated and uncoated paperboard mills, consumer packaging converting operations and merchandising display facilities, and Recycling, which consists of its recycled fiber brokerage and collection operations. On June 22, 2012, the Company acquired Mid South Packaging LLC. On October 28, 2011, the Company acquired four entities doing business as GMI Group.

Corrugated Packaging Segment

The Company is a producer of linerboard and corrugated medium (containerboard) measured by tons produced and a producer of graphics pre- printed linerboard in North America. It operates an integrated system, which manufactures containerboard, corrugated sheets, corrugated packaging and preprinted linerboard for sale to industrial and consumer products manufacturers and corrugated box manufacturers. It produces a range of corrugated containers designed to protect, ship, store and display products made to its customers’ merchandising and distribution specifications. It also converts corrugated sheets into corrugated products ranging from one-color protective cartons to point-of-purchase packaging. Corrugated packaging is used to provide protective packaging for shipment and distribution of food, paper, health and beauty and other household, consumer, commercial and industrial products and in the case of graphically enhanced corrugated packaging for retail sale, particularly in club store locations and retail sale. It also provides structural and graphic design, engineering services, and custom and standard auto mated packaging machines, offering customers turn-key instal! lation, automation, line integration and packaging solutions. It feeds linerboard and corrugated medium into corrugators, which flutes the medium to specified sizes, glues the linerboard and fluted medium together and slits and cuts the resulting corrugated paperboard into sheets to customer specifications. Its container board mills and corrugated container operations are integrated with its containerboard production used internally by its corrugated container operations. During the fiscal year ended September 30, 2012 (fiscal 2012), sales of corrugated packaging products to external customers accounted for 65.7% of its net sales.

Consumer Packaging Segment

The Company operates an integrated system of coated recycled mills and a bleached paperboard mill, which produces paperboard for its folding carton operations and third parties. The Company is a manufacturer of folding cartons in North America measured by net sales. Its folding cartons are used t o package food, paper, health and beauty and other household consumer, commercial and industrial products for retail sale. It also manufactures express mail envelopes for the overnight courier industry. Folding cartons protect customers’ products during shipment and distribution and employ graphics to promote them at retail. It manufactures folding cartons from recycled and virgin paperboard, laminated paperboard and substrates with specialty characteristics, such as grease masking and microwaveability. It prints, coats, die-cuts and glues the cartons to customer specifications. It ships finished cartons to customers for assembling, filling and sealing. It employs a range of offset, flexographic, gravure, backside printing, and coating and finishing technologies. It supports its customers with package development, innovation and design services and package testing services.

The Company manufactures temporary and permanent point-of-purchase displays. The Compan y designs, manufactures and packs temporary displays for sal! e to cons! umer products companies. These displays are used as marketing tools to support new product introductions and specific product promotions in mass merchandising stores, supermarkets, convenience stores, home improvement stores and other retail locations. It also designs, manufactures and pre-assemble permanent displays for the same categories of customers. It makes temporary displays from corrugated paperboard. It provides contract packing services, such as multi-product promotional packing and product manipulation, such as multipacks and onpacks. The Company manufactures lithographic laminated packaging for sale to its customers, which require packaging with graphics and strength characteristics.

The Company operates an integrated system of specialty recycled paperboard mills, which includes its Seven Hills Paperboard LLC (Seven Hills) joint venture. Its specialty recycled paperboard mills, excluding Seven Hills, produce paperboard for its solid fiber interior pa ckaging converting operations and third parties, and its Seven Hills joint venture manufactures gypsum paperboard liner for sale to its joint venture partner. It sells its specialty recycled paperboard to manufacturers of solid fiber interior packaging, tubes and cores, and other paperboard products. It also converts specialty paperboard into book covers and other products. Its 65% owned subsidiary, RTS, designs and manufactures solid fiber and corrugated partitions and die-cut paperboard components. It manufactures and sells its solid fiber and corrugated partitions principally to glass container manufacturers and producers of beer, food, wine, spirits, cosmetics and pharmaceuticals and to the automotive industry. During fiscal 2012, sales of consumer packaging products to external customers accounted for 27.5% of its net sales.

Recycling Segment

The Company’s recycled fiber brokerage and collection operations provide a strategic advantage to its mills. Its recycling operations procure recovered paper (or! recycled! fiber) for its paper mills, as well as for third parties from factories, warehouses, commercial printers, office complexes, grocery and retail stores, document storage facilities, paper converters and other wastepaper collectors. It handles a range of grades of recovered paper, including old corrugated containers, office paper, box clippings, newspaper and print shop scraps. It operates recycling facilities, which collects, sorts, grades and bales recovered paper and after sorting and baling, it transfer recovered paper to its paperboard mills for processing, or sell it to the United States manufacturers of paperboard, as well as manufacturers of tissue, newsprint, roofing products and insulation and to export markets. It also collects aluminum and plastics for resale to manufacturers of these products. Its waste reduction services extract additional recyclables from the waste stream by working with customers. In addition, it operates a nationwide fiber marketing and broker age system, which serves regional and national accounts, as well as its recycled paperboard and containerboard mills and sells scrap materials from its converting businesses and mills. Brokerage contracts provide bulk purchasing. Its recycling facilities are located close to its recycled paperboard and containerboard mills, ensuring availability of supply with reduced shipping costs. During fiscal 2012, sales to external customers accounted for 6.8% of its net sales.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Shares of MeadWestvaco have jumped 4.6% to $37.29 today at 3:36 p.m. Other paper packaging companies, however, aren’t getting a boost from the news or from Merrill’s upgrade. Shares of Rock-Tenn (RKT) have dipped 0.1% to $100.34, International Paper (IP) has ticked up 0.1% to $48.74and Packaging Corp. of America (PKG) is little changed at $65.40.

  • [By Sean Williams]

    Boring doesn’t always mean “buy”
    You may have heard me mention recently that boring industries can often make the most profitable industries. That is generally true, but it’s not a rule! This is why packaging products maker Rock-Tenn (NYSE: RKT  ) has found its way onto my “sell-now” radar.

  • [By Eric Volkman]

    After rocking EPS expectations for its Q2 earlier this week, RockTenn (NYSE: RKT  ) is celebrating with a higher dividend. The company has declared a payout of $0.30 per share of its class A common stock, to be distributed on May 20 to shareholders of record as of May 7.

Best Dow Dividend Stocks To Own Right Now: MicroStrategy Incorporated(MSTR)

MicroStrategy Incorporated provides enterprise software platforms for business intelligence (BI), and mobile and social intelligence applications worldwide. The company offers MicroStrategy 9, an integrated BI platform that enables businesses to make business decisions. The MicroStrategy 9 platform?s product components comprise Intelligence Server, a foundation for the BI platform; Report Services, a reporting engine delivering production and operational reports, managed metrics reports, and interactive dashboards; OLAP Services that allows Web and desktop users to manipulate Intelligent Cubes databases; Web, a Web interface providing query, reporting, and analysis; Distribution Services that offers automated report and dashboard distribution; Office, which enables Microsoft Office users to create, run, edit, and format MicroStrategy report; and Desktop that provide users access to data through analytical applications. The MicroStrategy 9 platform?s product components al s o include Architect, whose data sources are modeled through an intuitive graphical user interface; SDK to integrate MicroStrategy 9 features and functionality into any application on multiple platforms; Integrity Manager to compare and verify reports? consistency; Command Manager that automates MicroStrategy administrative tasks; Enterprise Manager to provide prebuilt reports and dashboards; Object Manager that allows administrators to manage disparate and distributed environments; MultiSource Option allowing users to report, analyze, and monitor data; Transaction Services that provides write-back capabilities; and Clustering Option, a plug-and-play add-on to Intelligence Server. The company also offers technical support, consulting, education, and cloud-based solutions. It serves retail, communications, financial services, insurance, healthcare, manufacturing, technology, consumer goods, and public services industries. The company was founded in 1989 and is headquartered in Tysons Corner, Virginia.

Advisors’ Opinion:

  • [By Victor Selva]

    The second place was occupied by MicroStrategy Incorporated (MSTR), a provider of business intelligence and mobile software with 5.5% of the total portfolio and worth $52.6 million. It reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago, and the stock price outperformed the rise in the S&P 500.

  • [By John Udovich]

    Yesterday, small cap business intelligence stock MicroStrategy Incorporated (NASDAQ: MSTR) surged 18.44% after reporting better-than-expected third quarter earnings – meaning it might be a good idea to take a closer look at it along with small cap peers Actuate Corporation (NASDAQ: BIRT) and Qlik Technologies Inc (NASDAQ: QLIK) to see what they might offer small cap investors. After all, everyone is being inundated with huge amounts of data from multiple sources, but its the following small cap stocks that provide software platforms to help customers try to make sense of it all: